Intranasal booster using an Omicron vaccine confers broad mucosal and systemic immunity against SARS-CoV-2 variants
Qian Wang(Aaron Diamond AIDS Research Center), Nanshan Zhong(First Affiliated Hospital of Guangzhou Medical University), Pingchao Li(Chinese Academy of Sciences), Suhua Guan(Guangzhou Experimental Station), Hengchun Li(Chinese Academy of Sciences), Liqiang Feng(Chinese Academy of Sciences), Chunhua Wang(Guangzhou Regenerative Medicine and Health Guangdong Laboratory), Xiaolin Liu(Hebei Medical University), Ling Chen(First Affiliated Hospital of University of South China), Bo Liu(Guangzhou Regenerative Medicine and Health Guangdong Laboratory), Zhengyuan Zhang(Chinese Academy of Sciences), Jing Sun(First Affiliated Hospital of Guangzhou Medical University), Zijian Liu(Chinese Academy of Sciences), Si Chen(Jilin University), Li Yin(Chinese Academy of Sciences), Ying Feng(First Affiliated Hospital of Guangzhou Medical University), Linjing Shi(Chinese Academy of Sciences), Wei Wang(Sun Yat-sen University), Xuefeng Niu(First Affiliated Hospital of Guangzhou Medical University), Linbing Qu(Guangzhou Institutes of Biomedicine and Health), Chenchen Yang, Jincun Zhao(ShanghaiTech University)
Cited by 31
Related Papers
Correction: Corrigendum: The Serum Profile of Hypercytokinemia Factors Identified in H7N9-Infected Patients can Predict Fatal Outcomes
|Scientific Reports|2016|2.1k
Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity
|Nature|2002|1.2k
Clinical Findings in 111 Cases of Influenza A (H7N9) Virus Infection
|New England Journal of Medicine|2013|654
Kinetics of SARS-CoV-2 specific IgM and IgG responses in COVID-19 patients
|Emerging Microbes & Infections|2020|535
Identification of antimicrobial peptides from the human gut microbiome using deep learning
|Nature Biotechnology|2022|470